Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04447943 in mild to moderate Alzheimer's disease
NCT00930059Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of edelinontrine in Alzheimer's disease (AD), sponsored by Pfizer. Started Sep 2009; status: completed.
02
Drugs
edelinontrine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00930059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930059.